Sep 22, 2026 5 0
Uploaded by Stanford
Favorite
Share
More Options
17
DTX3L promotes ovarian cancer progression and cisplatin resistance by activating JAK1/STAT1/OAS3 pathway_Page 1

Open in WPS to view all 17 pages